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The pathogenic role of the spv (Salmonella plasmid virulence) genes of Salmonella dublin was determined in
the natural, bovine host. Since the lack of overt signs of enteritis or enterocolitis due to Salmonella infections
in mice has limited the development of a convenient experimental system to study enteric disease, we used
calves to study the contribution of the spv genes to S. dublin-induced salmonellosis. Since the SpvR transcrip-
tional regulator is required for expression of the spvABCD operon, we constructed an spvR knockout mutation
in a calf-virulent strain of S. dublin. Calves were infected with the wild-type strain, an spvRmutant, and an spvR
mutant containing a complementing plasmid. Calves that were infected with the wild type or the complemented
spvR mutant rapidly developed severe diarrhea and became moribund. Calves that were infected with the spvR
mutant showed little or no clinical signs of systemic salmonellosis and developed only mild diarrhea. The
survival and growth of the wild-type strain and the spvRmutant were determined by using blood-derived bovine
monocytes. Wild-type S. dublin survived and grew inside cells, while the spvR mutant did not proliferate. These
results suggest that the spv genes of S. dublin promote enhanced intracellular proliferation in intestinal tissues
and at extraintestinal sites in the natural host.
Members of the genus Salmonella infect a wide variety of
vertebrate hosts, including reptiles, birds, and mammals. Nat-
ural infection involves ingestion of organisms and colonization
of the gastrointestinal tract. Although enteritis is a common
feature of salmonellosis, involvement of systemic tissues with
or without intestinal disease is an important complication of
infection. The manifestations of Salmonella infection depend
on both host and bacterial factors. The lack of overt signs of
enteritis or enterocolitis in mice, the major animal model for
salmonellosis, has limited the development of a convenient
experimental system with which to study enteric disease. Al-
though a large number of nontyphoid Salmonella serovars have
been associated with enteritis in humans and large-animal
hosts such as cattle and swine (45), certain serovars are par-
ticularly associated with systemic infections, and these strains
are capable of producing lethal infections in experimental
models using mice or chickens. A common feature of these
serovars is the presence of the plasmid-encoded spv genes,
which enhance the virulence of these strains in systemic models
of disease (23, 24, 29). The spv genes from different serovars
are highly homologous, and they are found in nearly all natural
isolates of Salmonella that are host adapted to animals (Sal-
monella dublin, S. choleraesuis, S. gallinarum-pullorum, and S.
abortusovis) but not in S. typhi. Plasmid-encoded spv genes are
also found in the common broad-host-range serovars S. typhi-
murium and S. enteritidis, but only a variable proportion of
isolates carry these virulence plasmids.
The spv locus consists of five genes, designated spvRABCD,
with spvABCD organized as an operon (36). spvR encodes a
MetR/LysR-type transcriptional activator and is transcribed
separately from the spvABCD structural genes. SpvR binds to
both the spvR and spvA promoters and is required for expres-
sion of the spvABCD genes (17, 22, 36). Transcription from
both the spvR and spvA promoters is induced during stationary
phase under control of the alternative sigma factor RpoS (11,
17, 18, 35). The spv genes are strongly expressed by S. typhi-
murium and S. dublin following uptake of the bacteria into
eukaryotic cells (19, 48). The intracellular induction of the spv
locus is controlled by both SpvR and RpoS (12, 19).
The spv genes were initially defined on the basis of their
ability to enhance the virulence of Salmonella serovars capable
of producing lethal disease in mice (23, 24, 29). In general, the
spv genes decrease the 50% lethal doses of strains for mice 10-
to 106-fold, depending on the serovar and route of infection. In
studies using the murine model, the spv genes have been shown
not to affect colonization of the bowel or invasion through the
intestinal mucosa, and they are not required for Salmonella to
infect extraintestinal tissues such as the liver and spleen (27,
32, 42, 46). However, the spv genes significantly increase the
growth rate of organisms within these tissues, probably in an
intracellular compartment (20, 21, 29, 32). Attempts to dem-
onstrate spv-mediated differences in growth within murine
macrophages in vitro have been unsuccessful (27, 49).
Investigation of the role of the spv genes in nonmurine hosts
has been limited. The virulence plasmid of S. gallinarum is
required for the syndrome of fowl typhoid, a disseminated
infection not characterized by enteritis (3). In swine, the plas-
mid of S. choleraesuis enhanced systemic disease when the
strains were given by intravenous inoculation, but oral infec-
tion was not tested (16). The effect of the S. dublin virulence
plasmid has been tested in calves, using both naturally occur-
ring plasmid-free strains as well as a plasmid-cured derivative
(53). This study showed that the mortality of calves infected
with the plasmid-cured strain was less than that of animals
given a comparable dose of wild-type organisms. In addition,
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the majority of the calves infected with the plasmid-cured de-
rivative as well as the wild-type parent strain developed diar-
rhea, although the severity of the diarrhea was not reported. In
each of these studies, the effect of the entire virulence plasmid,
rather than the specific function of the spv locus, was investi-
gated.
Our hypothesis was that definition of the role of the spv
genes of S. dublin for infection of the natural host, cattle,
would reveal a clearer understanding of the pathogenesis un-
attainable in the mouse model. These studies demonstrate that
expression of the spv locus is required for production of severe
enteritis as well as lethal disease in young calves. Furthermore,
the use of primary bovine macrophages reveals a difference in
the intracellular survival between wild-type S. dublin and an spv
mutant.
MATERIALS AND METHODS
Bacterial strains, growth media, and plasmids. The bacterial strains and
plasmids used in this study are listed in Table 1. Wild-type SL2260 was obtained
from Patricia Blanchard, California Veterinary Diagnostic Laboratory, Univer-
sity of California, Davis, Tulare, Calif. Bacteria were grown in LB medium, and
antibiotics were added as needed: penicillin, 200 mg ml21; tetracycline, 10 mg
ml21; and kanamycin, 50 mg ml21.
Strain construction and cloning. The virulence plasmid in S. dublin SL2260
was eliminated by methods previously described by our laboratory (14). Loss of
the virulence plasmid was confirmed by Southern analysis and probing with the
14-kb SalI fragment from pCR4 containing the entire spv operon (37, 50). To
construct an spvR mutant of SL2260, a P22 lysate was made on S. dublin Lane
pSDL15-1 harboring a Tn5-oriT insertion in the spvR gene (4) as described
previously (11). The resulting lysate was used to transduce SL2260 to kanamycin
resistance, and resulting transductants were purified on EBU medium containing
kanamycin to screen for phage-free colonies (41). Verification of the interruption
of the spvR gene on the virulence plasmid in SL2260 was by Southern hybrid-
ization, and this strain was designated SL2403. Chromosomal DNA preparations
were performed as previously described (39), and Southern hybridization and
detection were performed with an Amersham ECL kit as instructed by the
manufacturer.
Cloning of the spvR gene in pSC101 for complementation. To complement the
spvR mutation in SL2403, the 2.3-kb SalI/EcoRI fragment from pFF18 (17) was
cloned into the EcoRI site of pSC101 (15). pFF18 was restricted with SalI/EcoRI
and treated with Klenow enzyme, and the 2.3-kb fragment containing the func-
tional spvR gene was purified by gel electrophoresis and electroelution. pSC101
was restricted with EcoRI, the ends were made blunt by treatment with Klenow
enzyme and ligated with the spvR fragment, and the plasmid was transformed
into DH5a; the transformants were selected on LB agar containing tetracycline.
Cloning of the spvR fragment into pSC101 was verified by restriction digests.
Plasmid DNA was prepared from a clone containing pSC101-spvR (pSB2300)
and electroporated into SL2403 by methods described previously (31), and trans-
formants were selected on tetracycline- and kanamycin-containing LB agar.
Mouse infection studies. Female BALB/c mice were injected intraperitoneally
with 23 104 to 53 104 CFU of an overnight culture of SL2260, SL2297, SL2403,
or SL2495 grown in the appropriate antibiotics. Mice that received wild-type
SL2260 or SL2495 died within 3 to 5 days or were euthanatized if they became
moribund. Mice that received SL2297 or SL2403 had no signs of salmonellosis,
yet analysis of the livers and spleens revealed infection with the Salmonella
strains used.
Calf infection studies. Twenty-one-day-old Friesian-Holstein calves were pur-
chased from a local dairy (Dublin, Tex.) and maintained on antibiotic-free milk
replacer. Fecal and blood samples of all calves were cultured prior to experi-
mental infection and were negative for Salmonella. Overnight cultures of S.
dublin were grown in LB broth with the appropriate antibiotics in Fernbach
flasks. The cell density of S. dublin grown in this manner reaches approximately
2 3 109 to 5 3 109 cells per ml. Calves were infected orally with 2 3 1011 to 5 3
1011 bacteria either in LB or in a solution of 5% magnesium trisilicate, 5%
sodium bicarbonate, and 5% magnesium carbonate to reduce stomach acid. This
dose was chosen to ensure reproducible disease in all animals infected with the
wild type. Calves were weighed, blood and fecal samples were collected for
culture, and clinical signs were noted daily. Calves that became moribund were
euthanatized. The extent of diarrhea was scored by using the arbitrary scale
described in reference 44 as follows: 0, normal feces with distinct conformation;
1, normal feces without distinct conformation; 2, soft feces with loss of distinct
conformation; 3, loose feces with reduced solid matter; 4, running or watery feces
with significantly reduced or little solid matter, with occasional blood stains
and/or shreds of fibrinous membranes. Behavioral signs such as anorexia or
depression were also noted. Animals surviving for 10 days were euthanatized.
Necropsy was performed, and tissues were prepared for histopathology and
cultured for bacteria.
Necropsy, culture methods, and histopathology. Samples of feces were col-
lected in sterile plastic bags, and samples of jugular venous blood were inocu-
lated into blood culture medium (Difco). Fecal samples were transferred to
XLT4 agar (Difco) plates and to tetrathionate broth enrichment (BBL) tubes via
sterile cotton-tipped swabs. The plates and tubes were incubated overnight at
378C. The tetrathionate samples were then subsequently transferred to XLT4
agar plates and incubated overnight at 378C. Blood cultures were incubated
initially for 24 h at 378C before plating on XLT4 agar.
Tissue samples of liver, lung, spleen, mesenteric lymph node, Peyer’s patch,
kidney, ileum, jejunum, cecum, and colon were collected at necropsy and sub-
mitted for culture. Organ tissues (liver, lung, spleen, mesenteric lymph node, and
kidney) were seared with a hot spatula to reduce surface contamination, cut with
a sterile scalpel, and swabbed. Gut tissue and Peyer’s patches were swabbed
directly on the mucosal surface. Swabs were then treated as described above. The
tissues listed above were collected in 10% buffered formalin, embedded in
paraffin, sectioned at 5 mm, stained with hematoxylin and eosin, coded for
blinded examination, and viewed by light microscopy.
Macrophage culture and infection.Macrophage infection assays were done as
previously described by our groups (5–10, 19, 39, 47). Briefly, bovine venous
blood was collected in Alsever’s solution anticoagulant and diluted 1:1 with
phosphate-buffered saline–citrate, and the mononuclear cells were collected by
centrifugation onto Percoll. Cells were washed three times and resuspended in
RPMI 1640 supplemented with 4% autologous bovine serum. Cells were allowed
to adhere overnight in Teflon flasks, and the nonadherent population was re-
moved by washing. Monocytes were allowed to differentiate into macrophages
over 10 days in RPMI 1640 supplemented with 12% autologous serum. For
infection with S. dublin, macrophages were harvested from the Teflon flasks,
counted, seeded at a density of 105 cells per well into microtiter plates, centri-
fuged, and allowed to adhere overnight. Macrophage wells were then infected
with S. dublin grown under conditions that have been shown not to express the
inv locus, which is associated with macrophage cytotoxicity (13, 43). Macro-
phages were infected at a multiplicity of infection of 5 and centrifuged to
optimize contact between bacteria and macrophages. After 30 min, extracellular
bacteria were removed by washing and residual extracellular organisms were
killed by the addition of gentamicin at 20 mg/ml. At each time point, triplicate
wells were harvested by lysis of the macrophages in 1% deoxycholate, and the
number of viable bacteria was determined by serial dilution and plate count.
TABLE 1. Strains and plasmids used
Strain or plasmid Genotype Source or reference
Salmonella
SL2260 Wild type, virulent, virulence plasmid pSD2260 Pat Blanchard
SL2297 SL2260 plasmid cured This study
SL2303 S. dublin Lane pSD6 14
SL2403 SL2260 spvR::Tn5::oriT This study
SL2495 SL2403 pSB2300 This study
E. coli DH5a endA1 hsdR17 (rk
2 mk
1) supE44 thi-1 recA1 pyrA(Nalr) relA1 D(lacIAA-argF) U169 deoR[f80dlacD(lacZ)M15] Lab stock
Plasmids
pSC101 Wild-type plasmid with a single EcoRI site, Tetr 15
pFF18 2.3-kb SalI/EcoRI fragment contained spvR in pUC18 17
pSB2300 2.3-kb SalI/EcoRI spvR fragment from pFF18 cloned in the EcoRI site of pSC101 This study
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RESULTS
Strain construction and mouse virulence. A clinical isolate
of S. dublin (now called SL2260) was obtained from a calf that
died of S. dublin septicemia. All strains used in these studies
are isogenic derivatives of this isolate. We constructed an spvR
mutation in SL2260 by P22 transduction of an spvR::Tn5-oriT
insertion from a construct previously made in our laboratory
(4). The virulence plasmid in SL2260 was cured by methods
previously described by our laboratory (4, 14) and confirmed
by Southern hybridization (data not shown). To complement
the spvR mutation in SL2403 in trans, the intact spvR gene was
cloned into the EcoRI site of pSC101 (15). We have used
pSC101 as a stable cloning vector for Salmonella to comple-
ment other mutations (39).
Wild-type SL2260, virulence plasmid-cured SL2297, spvR
mutant SL2403, and SL2495 (containing the complementing
plasmid) were tested for virulence in BALB/c mice. Mice re-
ceived 104 organisms by the intraperitoneal route of infection.
These results are shown in Table 2. Both wild-type SL2260 and
SL2495 were virulent in mice, but the strains lacking the viru-
lence plasmid (SL2297) or harboring an spvR mutation
(SL2403) did not kill the mice even at this relatively high dose.
SL2403 and SL2297 could be isolated from the livers and
spleens of these mice (data not shown). These results confirm
our earlier report that the spv region is required for the patho-
genesis of S. dublin (38) and demonstrate that the spvR mutant
can be complemented by the cloned spvR region on pSC101.
These isogenic strains were used to infect calves in the exper-
iments described below.
spvR is required for the pathogenesis of S. dublin. Salmonella
dublin is a host-adapted serovar that causes a systemic and
often fatal disease in young animals and a chronic infection in
older animals, providing the source for continued herd infec-
tion (33). The calf model of S. dublin infection has been used
to determine virulence of wild-type S. dublin (52) and several
genetically defined mutants of S. dublin, including aroA (34,
44) and virulence plasmid-cured (53) strains. Wallis et al. (53)
reported that the virulence plasmid of S. dublin is required for
fatal systemic infection rather than the enteric phase of the
disease. To determine the role of the spvR gene, we chose to
compare the virulence of the wild type and an spvR mutant in
calves. Friesian-Holstein bull calves (14 to 21 days old) were
purchased from a local dairy (Dublin, Tex.) and maintained on
antibiotic-free milk replacer for 2 weeks. Fecal and blood sam-
ples of all calves were cultured to exclude the possibility of
prior infection with Salmonella.
Two groups of three calves were orally infected with either
wild-type SL2260 or the spvR mutant SL2403 at a final dose of
1011 CFU. The calves infected with SL2260 rapidly developed
clinical signs of salmonellosis manifested by severe diarrhea,
anorexia, and lethargy. Calves infected with SL2403 did not
show any of these signs; they ate well and were alert and active.
The clinical severity of enteric disease in the two groups is
shown in Fig. 1. Interestingly, there was no significant differ-
ence in the mean daily body temperature between calves in-
fected with the wild type and those infected with the spvR
mutant throughout the course of the experiment (data not
shown). Calves infected with SL2403 did have mild diarrhea,
but none of these animals developed the severe, debilitating
diarrhea seen in all of the animals infected with the wild-type
strain. Within 7 days, all of the calves that were infected with
wild-type organisms required euthanasia.
Culture results (Table 3) show that S. dublin grew in fecal
samples from all animals in both groups by day 4 after inocu-
lation. Calves infected with the spvR mutant had slightly fewer
positive blood cultures. The finding that all animals infected
with the spvR mutant eventually became blood culture positive
on days 6 and 7 shows that this strain is able to invade from the
intestinal tract and cause significant bacteremia, a result also
seen in the mouse model. In summary, the results of this
experiment suggest that the spv genes are involved in the
pathogenesis of both severe enteric and systemic infections of
calves.
FIG. 1. Average daily fecal scores of calves infected with either wild-type
SL2260 or spvR mutant SL2403. Fecal scores, a measure of the severity of
diarrhea, were determined each day for calves according to the scale described
in Materials and Methods. Calves that were infected with the wild type rapidly
developed severe diarrhea, while calves infected with the spvR mutant did not. p,
by day 7 postinfection, calves infected with the wild type had died or were
euthanatized.
TABLE 2. Virulence of S. dublin strains in micea
Strain Phenotype No. dead
SL2260 Wild type, plasmid containing 3
SL2297 Plasmid cured 0
SL2403 spvR mutant 0
SL2495 SL2403 with pSC101-spvR 3
a Six-week-old BALB/c mice were infected i.p. with 104 bacteria. Each group
contained three mice.
TABLE 3. Summary of culture results for calves infected with
SL2260 and SL2403
Day
postinfection
No. of calvesa with:
Positive fecal culture Positive blood culture
SL2260 SL2403 SL2269 SL2403
0 0 0 0 0
1 1 1 0 0
2 2 1 3 2
3 3 2 2 1
4 3 3 3 1
5 3 3 3 3
6 3 3 3 3
7 Died 3 Died 0
a Each group contained three calves.
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Complementation of the spvR mutation in vivo in calves.
Having established that expression of the spv operon is re-
quired for virulence in calves, we complemented the defect by
supplying spvR in trans on a stable, low-copy-number plasmid.
To ensure a more uniform survival of the infecting strains in
the acidic environment of the abomasa of the calves main-
tained on milk replacer (51), we chose to infect with the bac-
teria suspended in a 5% solution of magnesium trisilicate,
sodium bicarbonate, and magnesium carbonate (53). Three
groups of calves were infected with either the wild type
(SL2260), an spvR mutant (SL2403), or the complemented
spvR mutant (SL2495). Wild-type-infected calves became fe-
brile and lethargic within 24 h, developing grayish yellow, fetid
feces which accumulated in the perineal region. These signs
worsened as the wild-type-infected calves developed a more
profound, bloody mucoid diarrhea and became more febrile
and dehydrated, with all of the calves dying by the fifth day
after infection. Analysis of blood and fecal culture data showed
that they rapidly developed enteric and systemic infections
(Table 4). Three of the four calves that were infected with
SL2495, the complemented spvRmutant, became sick and died
within 8 days. These animals rapidly developed severe diarrhea
and bacteremia, indicating a systemic infection. Although all
calves received the same inoculum of bacteria, one of the four
calves survived, although this single animal was weak and did
not eat well. Calves that were infected with the spvR mutant
did not become sick and showed no signs of serious salmonel-
losis for the duration of the experiment, although one calf died
of a non-Salmonella pneumonia. As in the first experiment,
some animals infected with the spvR mutant developed a tran-
sient, mild diarrhea. There was no significant difference in the
daily body temperature among the calves. The fact that the
complemented spvR mutant caused disease and mortality at
approximately the same rate as the wild type demonstrates in
vivo complementation for virulence.
At necropsy, calves infected with wild-type S. dublin were
found to have severe intestinal and extraintestinal disease. The
bowel lumen was distended, and the ileum exhibited an acute
fibrinohemorrhagic enteritis. Histologic examination of the il-
eal mucosa revealed extensive exfoliation with blunting and
destruction of the villous architecture (Fig. 2B). A dense in-
flammatory infiltrate consisting of large numbers of neutro-
phils as well as mononuclear cells was seen. Occasionally, thin
layers of fibrinocellular exudate were attached to the blunted
villi. Fibrin thrombi were observed in submucosal capillaries of
the ileum associated with edema. The livers of these calves
infected with the wild-type strain had randomly distributed
small foci of necrosis and associated reactive microgranuloma
formation of the classical paratyphoid nodule type (Fig. 2C).
The intestines from calves infected with the spvR mutant ap-
peared normal, with no histopathology (Fig. 2A). Animals
infected with the complemented spvR strain SL2495 had fluid-
distended bowels indicative of catarrhal enteritis, with less
fibrinohemorrhagic change than in wild-type-infected calves.
Histology showed moderate inflammatory infiltrates with bet-
ter preservation of the villous architecture. Cultures of tissues
at necropsy showed widespread involvement with S. dublin in
the intestines, Peyer’s patches, mesenteric nodes, and systemic
organs (spleen, liver, lungs, and kidneys) of wild-type-infected
animals. Positive cultures were more sporadic for the spvR
mutant, with the majority of animals from both experiments
having negative spleen and liver cultures, while most host tis-
sues were positive for the spvR-complemented strain. The mor-
tality and major necropsy findings are summarized in Table 5.
Although the clinical disease was less rapid for the comple-
mented strain than for the wild-type strain, and the necropsy
findings were not as severe, this strain was clearly capable of
producing significant enteritis and ultimately fatal disease, in-
dicating functional complementation of the spvR mutation.
The spv genes are required for in vitro growth in bovine
blood-derived monocytes. Both plasmid-cured and spvR mu-
tants of S. dublin grow equally well in broth or defined medium
and in cultured murine macrophages. Our laboratory and oth-
ers have speculated that the role of the spv genes on the
virulence plasmid is to facilitate bacterial survival and replica-
tion in the tissues of the host, primarily inside macrophages
(23–27, 32).
To test this hypothesis, we compared the survival and growth
of the wild type, the spvR mutant, and the complemented spvR
mutant in monocyte-derived bovine macrophages. Venous
blood was collected, and monocytes were purified and allowed
to differentiate into macrophages over 5 to 8 days in RPMI
1640 supplemented with autologous serum. Macrophages were
infected with bacteria and at each time point, triplicate wells
were harvested by lysis of the macrophages, and the number of
viable bacteria was determined by serial dilution and plate
count. These results are shown in Fig. 3. Wild-type SL2260
survived and grew in these cells, increasing in number over 6 h,
while the spvR mutant did not proliferate. The complemented
spvR mutant showed intermediate growth in these cells but
grew significantly more than the spvR mutant. These results
demonstrate a difference in the abilities of spv1 and spv bac-
teria to proliferate inside bovine macrophages that closely par-
allels the difference in virulence seen in the calf infection
experiments.
DISCUSSION
Use of the bovine host of S. dublin to study the role of the
virulence plasmid spv genes provides a unique opportunity to
determine the molecular mechanisms of natural infection and
host adaptation. These studies in calves demonstrate that the
TABLE 4. Summary of culture results for calves infected with SL2260, SL2403, and SL2495a
Day
postinfection
No. of calves/total
Positive fecal culture Positive blood culture With diarrhea
SL2260 SL2403 SL2495 SL2260 SL2403 SL2495 SL2260 SL2403 SL2495
0 0/3 0/3 0/4 0/3 0/3 0/4 0/3 0/3 0/4
1 3/3 3/3 4/4 3/3 0/3 3/4 3/3 1/3 2/4
2 3/3 3/3 4/4 3/3 0/3 3/4 3/3 1/3 4/4
a Daily blood and fecal samples were taken for culture. Within 2 days postinfection, calves that had been infected with wild-type SL2260 or the complemented spvR
mutant SL2495 developed severe diarrhea and had S. dublin in their blood and feces. Calves that were infected with SL2403, the spvR mutant, had detectable levels
of Salmonella in fecal cultures but had only sporadic diarrhea and did not develop positive blood cultures over this period. By the third day, calves in the SL2260 group
began to require euthanasia.
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S. dublin virulence plasmid spv genes affect both enteric and
systemic disease processes. Previous experimental approaches
have shown that the spv genes enhance the ability of nonty-
phoid Salmonella strains to cause progressive extraintestinal
infection, but the role of these genes in intestinal disease was
not clear (23, 24, 29). We used a specific mutation in spvR to
demonstrate that the spv locus, rather than other genes on the
S. dublin virulence plasmid, were essential for the virulence
effect in calves. In addition, we were able to complement the
spvR mutant by using a cloned spvR gene. This finding proves
that the defect in spvR is responsible for the attenuation of the
mutant.
Extensive studies of mice have established that the spv genes
increase the proliferation of Salmonella in a variety of tissues
(27, 32, 46). Although organisms are found in the bowel wall
and Peyer’s patches after oral inoculation, mice develop nei-
ther clinical evidence of intestinal disease nor the pathologic
findings of inflammatory enteritis. This deficiency of the mouse
model has severely limited the identification of Salmonella
genes that have a role in enteric virulence. In contrast, large
domestic animals such as cattle frequently develop diarrhea as
a manifestation of salmonellosis, and calves can exhibit severe
enteritis with dehydration as a complication of infection by
particularly virulent strains such as S. dublin (52). Our findings
underscore the value of testing defined mutants for virulence
in the natural host, since the mouse studies predicted only the
systemic virulence phenotype of the spv genes, not the effect on
enteric disease.
The mechanism of action of the spv genes has not been fully
elucidated. Based on studies of mice, the spv genes appear to
enhance the growth rate of the organism within an intracellular
compartment (30). In coinfection experiments between iso-
genic spv1 and virulence plasmid-cured spv strains, the spv1
organisms do not increase the growth of spv bacteria, suggest-
ing that the spv genes do not have a global or even local effect
on the host response (28). Instead, spv1 bacteria outgrow the
virulence plasmid-cured spv organisms. Although macrophages
in the liver and spleen are postulated to be major targets for
the intracellular growth of virulent Salmonella, studies of
mouse macrophage infection in vitro have failed to demon-
strate a difference in macrophage survival between spv1 and
spv strains (27, 49). Due to these problems in the mouse sys-
tem, we used primary bovine monocyte-derived macrophages
to study the role of the spv genes in cells from the natural host.
FIG. 2. Histopathology of ileal sections from calves infected with either SL2403 or SL2260. (A) Histologically normal ileum of a calf infected with S. dublin spvR
mutant SL2403. (B) Acute erosive ileitis of a calf infected with S. dublin wild-type SL2260, demonstrating severe exfoliation and blunting of villi massively infiltrated
with neutrophils and mononuclear cells. (C) Reactive hepatic microgranuloma (paratyphoid nodule) from a calf infected with SL2260.
TABLE 5. Summary of calf infection experiments
Expt No. dead/total Necropsy finding
1
SL2260 3/3 Acute catarrhal enteritis with regional
fibrinohemorrhagic ileitis
SL2403 0/3 Normal bowel appearance
2
SL2260 3/3 Acute catarrhal enteritis with regional
fibrinohemorrhagic ileitis
SL2495 3/4 Acute catarrhal enteritis
SL2403 0/3 Normal bowel appearance
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We were able to demonstrate a reproducible difference in
macrophage survival between wild-type S. dublin and the spvR
derivative. There are a number of possible reasons for the
differences between the results in mouse and bovine cells. The
in vitro macrophage survival assay requires a subtle balance
between intracellular growth and killing, and the population of
bacteria is heterogeneous (1, 2, 7). If bacteria grow too rapidly
and/or exert a cytotoxic effect, the macrophage will die and the
bacteria will be killed by the extracellular gentamicin (40). We
postulate that primary bovine macrophages are able to par-
tially restrict the cytotoxicity of wild-type S. dublin, allowing the
differences in survival of the mutants to be measured in this
assay.
On the basis of our results in the bovine host, we propose
that the spv genes enhance proliferation of S. dublin in both
intestinal tissue and extraintestinal sites. The macrophage is
likely to be a major target cell for S. dublin in all organs. In the
intestine, Peyer’s patch lymphoid tissue is rich in macrophages.
However, the spv locus may also enhance bacterial growth in
other cell types, since induction of spv gene expression occurs
inside intestinal epithelial cells as well as macrophages (19).
The severe mucosal destruction seen in Fig. 2B suggests wide-
spread involvement of the epithelium by the spv1 strain.
While the spv genes clearly affect the severe enteritis pro-
duced by S. dublin in young calves, spv-containing virulence
plasmids are not required by Salmonella serovars in general to
produce intestinal disease. Many Salmonella strains isolated
from human and animal cases of gastroenteritis do not contain
virulence plasmids. However, our results suggest that in sero-
vars that carry virulence plasmids, the spv genes can enhance
the severity of the enteric infection and can produce lethal
disease.
ACKNOWLEDGMENTS
This work was supported by grants from the National Institutes of
Health (AI-32178 and DK-35108 to D.G.G.) and the U.S. Department
of Agriculture (93-37204 to D.G.G.).
We are grateful to Patricia Blanchard for providing S. dublin strains.
We especially thank Roberta Pugh and Doris Hunter for preparing the
bovine monocytes and Joel Shields for taking care of the calves.
REFERENCES
1. Abshire, K. Z., and F. C. Neidhardt. 1993. Analysis of proteins synthesized
by Salmonella typhimurium during growth within a host macrophage. J.
Bacteriol. 175:3734–3743.
2. Abshire, K. Z., and F. C. Neidhardt. 1993. Growth rate paradox of Salmo-
nella typhimurium within host macrophages. J. Bacteriol. 175:3744–3748.
3. Barrow, P. A., and M. A. Lovell. 1988. The association between a large
molecular mass plasmid and virulence in a strain of Salmonella pullorum.
J. Gen. Microbiol. 134:2307–2316.
4. Beninger, P. R., G. Chikami, K. Tanabe, C. Roudier, J. Fierer, and D. G.
Guiney. 1988. Physical and genetic mapping of the Salmonella dublin viru-
lence plasmid pSDL2. J. Clin. Invest. 81:1341–1347.
5. Buchmeier, N., and F. Heffron. 1990. Induction of Salmonella stress proteins
upon infection of macrophages. Science 248:730–732.
6. Buchmeier, N., and F. Heffron. 1991. Inhibition of macrophage phagosome-
lysosome fusion by Salmonella typhimurium. Infect. Immun. 59:2232–2238.
7. Buchmeier, N. A., and F. Heffron. 1989. Intracellular survival of wild-type
Salmonella typhimurium and macrophage-sensitive mutants in diverse pop-
ulations of macrophages. Infect. Immun. 57:1–7.
8. Buchmeier, N. A., S. J. Libby, Y. Xu, P. Lowewen, J. Switala, D. G. Guiney,
and F. C. Fang. 1995. DNA repair is more important than catalase for
Salmonella virulence in mice. J. Clin. Invest. 95:1047–1053.
9. Campbell, G. A., and G. L. Adams. 1992. The long term culture of bovine
monocyte-derived macrophages and their use in the study of intracellular
proliferation of Brucella abortus. Vet. Immunol. Immunopathol. 34:291–305.
10. Campbell, G. A., L. G. Adams, and B. A. Sowa. 1994. Mechanisms of binding
of Brucella abortus to mononuclear phagocytes from cows naturally resistant
or susceptible to brucellosis. Vet. Immunol. Immunopathol. 41:295–306.
11. Chen, C.-Y., N. A. Buchmeier, S. J. Libby, F. C. Fang, M. Krause, and D. G.
Guiney. 1995. Central regulatory role for the RpoS sigma factor in expres-
sion of Salmonella dublin plasmid virulence genes. J. Bacteriol. 177:5303–
5309.
12. Chen, C.-Y., L. Eckmann, S. J. Libby, F. C. Fang, S. Okamoto, M. F. Kagnoff,
J. Fierer, and D. G. Guiney. 1996. Expression of Salmonella typhimurium
rpoS and rpoS-dependent genes in the intracellular environment of eukary-
otic cells. Infect. Immun. 64:4739–4743.
13. Chen, L. M., K. Kaniga, and J. E. Galan. 1996. Salmonella spp. are cytotoxic
for cultured macrophages. Mol. Microbiol. 21:1101–1115.
14. Chikami, G. K., J. Fierer, and D. G. Guiney. 1985. Plasmid-mediated viru-
lence in Salmonella dublin demonstrated by use of a Tn5-oriT construct.
Infect. Immun. 50:420–424.
15. Cohen, S. N., and A. C. Y. Chang. 1978. Revised interpretation of the origin
of the pSC101 plasmid. J. Bacteriol. 132:734–737.
16. Danbara, H., R. Moriguchi, S. Susuke, Y. Tamura, M. Kijima, K. Oishi, H.
Matsui, A. Abe, and M. Kakmura. 1992. Effect of 50 kilobase-plasmid,
pKDSC50, of Salmonella choleraesuis RF-1 strain on pig septicemia. J. Vet.
Med. Sci. 54:1175–1178.
17. Fang, F. C., M. Krause, C. Roudier, J. Fierer, and D. G. Guiney. 1991.
Growth regulation of a Salmonella plasmid gene essential for virulence. J.
Bacteriol. 173:6783–6789.
18. Fang, F. C., S. J. Libby, N. Buchmeier, P. Loewen, J. Switala, and D. Guiney.
1992. Regulation of Salmonella virulence by an alternative sigma factor.
Proc. Natl. Acad. Sci. USA 89:11978–11982.
19. Fierer, J., L. Eckmann, F. Fang, C. Pferfer, B. B. Finlay, and D. Guiney.
1993. Expression of the Salmonella virulence plasmid gene spvB in cultured
macrophages and nonphagocytic cells. Infect. Immun. 61:5231–5236.
20. Fierer, J., and W. Fleming. 1983. Distinctive biochemical features of Salmo-
nella dublin isolated in California. J. Clin. Microbiol. 17:552–554.
21. Fierer, J., L. Hatlen, J. Lin, D. Estrella, P. Mihalko, and A. Ya-Young. 1990.
Successful treatment using gentamicin liposomes of Salmonella dublin infec-
tions in mice. Antimicrob. Agents Chemother. 34:343–348.
22. Grob, P., and D. G. Guiney. 1996. In vitro binding of the Salmonella dublin
virulence plasmid regulatory protein SpvR to the promoter region of spvA
and spvR. J. Bacteriol. 178:1813–1820.
23. Guiney, D. G., F. C. Fang, M. Krause, and S. J. Libby. 1994. Plasmid-
mediated virulence genes in non-typhoid Salmonella serovars. FEMS Micro-
biol. Lett. 3:275–279.
24. Guiney, D. G., F. C. Fang, M. Krause, S. J. Libby, N. Buchmeier, and J.
Fierer. 1995. Biology and clinical significance of virulence plasmids in Sal-
monella. Clin. Infect. Dis. 21:S146–S151.
25. Guiney, D. G., J. Fierer, G. Chikami, P. Beninger, E. J. Heffernan, and K.
Tanabe. 1988. Characterization of virulence plasmids in Salmonella, p. 329–
345. InM. A. Horwitz (ed.), Bacteria-host cell interaction. Alan R. Liss, Inc.,
New York, N.Y.
26. Gulig, P. A. 1990. Virulence plasmids of Salmonella typhimurium and other
Salmonellae. Microb. Pathog. 8:3–11.
27. Gulig, P. A., and R. I. Curtiss. 1987. Plasmid-associated virulence of Salmo-
nella typhimurium. Infect. Immun. 55:2891–2901.
28. Gulig, P. A., and R. I. Curtiss. 1988. Cloning and transposon insertion
FIG. 3. Survival of S. dublin strains in bovine blood-derived monocytes.
Blood-derived monocytes were prepared, allowed to differentiate for 7 days, and
then infected with wild-type SL2260, spvR mutant SL2403, and complemented
spvR mutant SL2495. Bacterial counts were averaged from triplicate wells for
each time point, the standard deviation was calculated, and the data were plot-
ted.
VOL. 65, 1997 spv GENES OF S. DUBLIN VIRULENCE PLASMID 1791
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
mutagenesis of virulence genes of the 100-kilobase plasmid of Salmonella
typhimurium. Infect. Immun. 56:3262–3271.
29. Gulig, P. A., H. Danbara, D. G. Guiney, A. J. Lax, F. Norel, and M. Rhen.
1993. Molecular analysis of spv virulence genes of the salmonella virulence
plasmids. Mol. Microbiol. 7:825–830.
30. Gulig, P. A., and T. J. Doyle. 1993. The Salmonella typhimurium virulence
plasmid increases the growth rate of salmonellae in mice. Infect. Immun.
61:504–511.
31. Hanahan, D., J. Jessee, and F. R. Bloom. 1995. Plasmid transformation of
Escherichia coli and other bacteria. Methods Enzymol. 204:63–113.
32. Heffernan, E. J., J. Fierer, G. Chikami, and D. Guiney. 1987. Natural history
of oral Salmonella dublin infection in BALB/c mice: effect of an 80-kilobase-
pair plasmid on virulence. J. Infect. Dis. 155:1254–1259.
33. Jones, G. W., D. K. Rabert, D. M. Svinarich, and H. J. Whitfield. 1982.
Association of adhesive, invasive and virulent phenotypes of Salmonella
typhimurium with autonomous 60-megadalton plasmids. Infect. Immun. 38:
476–486.
34. Jones, P. W., G. Dougan, C. Hayword, N. Mackensie, P. Collins, and S. N.
Chatfield. 1991. Oral vaccination of calves against experimental salmonello-
sis using a double aro mutant of Salmonella typhimurium. Vaccine 9:29–34.
35. Kowarz, L., C. Coynault, V. Robbe-Saule, and F. Norel. 1994. The Salmonella
typhimurium katF(RpoS) gene: cloning, nucleotide sequence, and regulation
of spvR and spvABCD virulence plasmid genes. J. Bacteriol. 176:6852–6860.
36. Krause, M., F. C. Fang, and D. G. Guiney. 1992. Regulation of plasmid
virulence gene expression in Salmonella dublin involves an unusual operon
structure. J. Bacteriol. 174:4482–4489.
37. Krause, M., and D. Guiney. 1991. Identification of a multimer resolution
system involved in stabilization of the Salmonella dublin virulence plasmid
pSDL2. J. Bacteriol. 173:5754–5762.
38. Krause, M., C. Roudier, J. Fierer, J. Harwood, and D. Guiney. 1991. Mo-
lecular analysis of the virulence locus of the Salmonella dublin plasmid
pSDL2. Mol. Microbiol. 5:307–316.
39. Libby, S. J., W. Goebel, A. Ludwig, F. Bowe, N. Buchmeier, G. Songer, F.
Fang, D. Guiney, and F. Heffron. 1994. A cytolysin from Salmonella typhi-
murium is required for survival in macrophages. Proc. Natl. Acad. Sci. USA
91:489–493.
40. Lindgren, S. W., I. Stojiljkovic, and F. Heffron. 1996. Macrophage killing is
an essential virulence mechanism of Salmonella typhimurium. Proc. Natl.
Acad. Sci. USA 93:4197–4201.
41. Maloy, S. R., V. J. Stewart, and R. K. Taylor. 1996. Genetic analysis of
pathogenic bacteria: a laboratory manual. Cold Spring Harbor Laboratory
Press, Plainview, N.Y.
42. Manning, E. J., G. D. Baird, and P. W. Jones. 1986. The role of plasmid
genes in the pathogenicity of Salmonella dublin. J. Med. Microbiol. 21:239.
43. Monack, D. M., B. Raupach, A. E. Hromockyj, and S. Falkow. 1996. Salmo-
nella typhimurium invasion induces apoptosis in infected macrophages. Proc.
Natl. Acad. Sci. USA 93:9833–9838.
44. Mukkur, T. K. S., K. H. Walker, D. Jones, E. Wronski, and D. N. Love. 1991.
Immunizing efficacy of aromatic-dependent Salmonella dublin in mice and
calves. Comp. Immunol. Microbiol. Infect. Dis. 14:243–256.
45. Neidhardt, F. C., J. L. Ingraham, K. B. Low, B. Magasanik, M. Schaechter,
and H. E. Umbarger (ed.). 1987. Escherichia coli and Salmonella typhi-
murium: cellular and molecular biology, vol. 2. American Society for Micro-
biology, Washington, D.C.
46. Pardon, P., M. Y. Popoff, C. Coynault, J. Marly, and I. Miras. 1986. Viru-
lence-associated plasmids of Salmonella serotype typhimurium in experimen-
tal murine infection. Ann. Inst. Pasteur 137B:47.
47. Qureshi, T., J. W. Templeton, and L. G. Adams. 1996. Intracellular survival
of Brucella abortus, Mycobacterium bovis BCG, Salmonella dublin, and Sal-
monella typhimurium in macrophages from cattle genetically resistant to
Brucella abortus. Vet. Immunol. Immunopathol. 50:55–66.
48. Rhen, M., P. Riikonen, and S. Taira. 1993. Transcriptional regulation of
Salmonella enterica virulence plasmid genes in cultured macrophages. Mol.
Microbiol. 10:45–56.
49. Riikonen, P., P. H. Makela, S. Sukupolvi, S. Taira, and H. Rhen. 1992. The
virulence plasmid does not contribute to growth of Salmonella in cultured
murine macrophages. Microb. Pathog. 13:281–291.
50. Roudier, C., J. Fierer, and D. G. Guiney. 1992. Characterization of transla-
tion termination mutations in the spv operon of the Salmonella virulence
plasmid pSDL2. J. Bacteriol. 174:6418–6423.
51. Ruckebusch, Y., L.-P. Phaneuf, and R. Dunlop. 1991. Physiology of small and
large animals. B. C. Decker, Inc., Philadelphia, Pa.
52. Segall, T., and A. A. Lindberg. 1991. Experimental oral Salmonella dublin
infection in calves: a bacteriological and pathological study. J. Vet. Med.
38:169–185.
53. Wallis, T. S., S. M. Paulin, J. S. Plested, P. R. Watson, and P. W. Jones. 1995.
The Salmonella dublin virulence plasmid mediates systemic but not enteric
phases of salmonellosis in cattle. Infect. Immun. 63:2755–2761.
Editor: P. E. Orndorff
1792 LIBBY ET AL. INFECT. IMMUN.
 o
n
 Septem
ber 21, 2018 by guest
http://iai.asm
.org/
D
ow
nloaded from
 
